Thursday, October 20, 2016 4:00:00 PM
Note is convertible to common shares (at option of note holders)at the lower of the cost of shares at the upcoming offering, or 150% of the closing price of the common shares when note was signed (something like $4.00 a share). The warrants are exercisable under the same terms 90 days after offering or after July of next year which ever comes first). The term of the loan is one year with quarterly interest payments. The loan can be repaid without penalty at 115% of the outstanding balance plus accrued interest.
Lot's of other provisions but that seems to be the major features. Making the leap of faith that the loan will carry them until major sales take place I would say it was a better deal than I would have expected investors to give them.
Recent SASI News
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 03/06/2024 02:09:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 10:11:48 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 02/12/2024 02:01:27 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 02/09/2024 10:30:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 01:25:51 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 01/30/2024 11:12:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 09:45:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 09:15:49 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/16/2024 09:30:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 01:32:12 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/10/2024 09:30:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 10:00:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 01:39:21 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 01:38:26 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 01:30:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 10:20:32 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/07/2023 01:35:07 PM
- Sigma Additive Solutions Announces Filing of Definitive Proxy Statement Relating to Proposed Acquisition and Shareholder Vote • Business Wire • 12/07/2023 01:31:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/01/2023 11:03:17 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2023 09:05:37 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM